Lipodox 50 and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Lipodox 50 and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: doxorubicin liposomal
Brand name: Doxil, Lipodox 50, Lipodox
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lipodox 50-Moxifloxacin
- Lipodox 50-Moxifloxacin (Systemic)
- Lipodox 50-Moxifloxacin Hydrochloride
- Lipodox 50-Moxifloxacin Injection
- Lipodox 50-Moxifloxacin Intravenous
- Lipodox 50-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Lipofen
- Moxetumomab pasudotox-tdfk Intravenous-Liposyn
- Moxetumomab pasudotox-tdfk Intravenous-Liposyn III
- Moxetumomab pasudotox-tdfk Intravenous-Liposyn II
- Moxetumomab pasudotox-tdfk Intravenous-LiproZonePak
- Moxetumomab pasudotox-tdfk Intravenous-Liptruzet